IGF2R and cancer: A regulatory circuit links the insulin/IGF system with cancer through the glycosylation status of IGF2R (de-Freitas-Junior et al., 2017); in one example, desialylation of insulin receptors controls the proliferation of L6 myoblasts (Arabkhari et al., 2010).